---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-137263"
form_type: "8-K"
ticker: "TXMD"
cik: "0000025743"
company_name: "TherapeuticsMD, Inc."
filed_at: "2023-05-05T23:59:59+00:00"
generated_at: "2026-06-15T18:13:26.172550+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# TherapeuticsMD enters $5M private placement with Rubric Capital

## Summary
- Agreement to sell up to 5M shares at volume-weighted average price, aggregate up to $5M.
- Initial drawdown of 312,525 shares at $3.6797/share upon stockholder approval.
- Stockholders must approve the private placement at the upcoming annual meeting.
- Net proceeds to be used for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001193125-23-137263
- form_type: 8-K
- ticker: TXMD
- cik: 0000025743
- company_name: TherapeuticsMD, Inc.
- filed_at: 2023-05-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/25743/000119312523137263/0001193125-23-137263-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/25743/000119312523137263/d440805d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-137263
- JSON: https://secwatch.observer/filing/0001193125-23-137263.json
- Plain text: https://secwatch.observer/filing/0001193125-23-137263.txt

## Key facts
- Material Agreements
  TherapeuticsMD, Inc. entered into Subscription Agreement with Rubric Capital Management LP valued at $5,000,000 (effective 2023-05-01).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Rubric Capital Management LP
  - Value: $5,000,000
  - Effective: 2023-05-01
  source text: On May 1, 2023, TherapeuticsMD, Inc., a Nevada corporation (the “Company”), entered into a Subscription Agreement (the “Subscription Agreement”) with Rubric Capital Management LP (the “Investor”), pursuant to which the Company agreed to sell to the Investor, or one or more of its affiliates, up to an aggregate of 5,000,000 shares of the Company’s common stock, par value $0.001 per share (the “Shares”), from time to time during the term of the Subscription Agreement, at a purchase price of the five-day volume-weighted average price of the Company’s common stock at the time of the sale of such Shares, at an aggregate purchase price of up to $5,000,000 (collectively, the “Private Placement”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/25743/000119312523137263/0001193125-23-137263-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.